Friday, June 10, 2022

< + > Baby Formula Blues: The Latest Regulatory Fiasco Reveals Problems Bigger Than The Recall Itself

As it is, infant formula is very difficult to manufacture and to keep compliant with FDA standards. The industry recognized the implications of the shutdown of the Abbott Nutrition plant and yet the FDA and the White House failed to connect on the issue.

No comments:

Post a Comment

< + > Oracle Health Bets Big on AI, Supply Chain, and Collaboration at 2025 Health Summit

At this year’s Oracle Health Summit in Orlando, the company rolled out a broad set of announcements that doubled down on AI while weaving it...